Edward Lindup
Profile
Edward Lindup worked as a Trustee at Lhasa Ltd.
Former positions of Edward Lindup
Companies | Position | End |
---|---|---|
Lhasa Ltd.
Lhasa Ltd. Miscellaneous Commercial ServicesCommercial Services Lhasa Ltd. is a non-profit organization that facilitates collaborative data-sharing projects in the pharmaceutical, cosmetics, and chemistry industries. The non-profit company is based in Leeds, UK. The British company has established a consortium called the Nitrites Data Sharing Initiative, which shares data on the level of nitrites in common excipients, solvents, and reagents. This enables consortium members to assess the variability and likelihood that a nitrate will react to form a nitrosamine. Lhasa is committed to enabling scientists to make better predictions on the safety of drugs, chemicals, and cosmetics by using existing data better and developing computer-aided reasoning and information systems for the advancement of science. The company offers in silico software solutions such as the Lhasa Carcinogenicity Database (LCDB), VITIC, DEREK NEXUS, and KAPTIS to support carcinogenicity risk assessments. Additionally, they offer DEREK NEXUS, VITIC, and Skin Sensitisation Defined Approach for use in skin sensitisation assessments and as an alternative to animal testing. The company was founded in 1983, and Chris Barber has been the CEO of the company since 2011. | Director/Board Member | 2018-06-19 |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
Lhasa Ltd.
Lhasa Ltd. Miscellaneous Commercial ServicesCommercial Services Lhasa Ltd. is a non-profit organization that facilitates collaborative data-sharing projects in the pharmaceutical, cosmetics, and chemistry industries. The non-profit company is based in Leeds, UK. The British company has established a consortium called the Nitrites Data Sharing Initiative, which shares data on the level of nitrites in common excipients, solvents, and reagents. This enables consortium members to assess the variability and likelihood that a nitrate will react to form a nitrosamine. Lhasa is committed to enabling scientists to make better predictions on the safety of drugs, chemicals, and cosmetics by using existing data better and developing computer-aided reasoning and information systems for the advancement of science. The company offers in silico software solutions such as the Lhasa Carcinogenicity Database (LCDB), VITIC, DEREK NEXUS, and KAPTIS to support carcinogenicity risk assessments. Additionally, they offer DEREK NEXUS, VITIC, and Skin Sensitisation Defined Approach for use in skin sensitisation assessments and as an alternative to animal testing. The company was founded in 1983, and Chris Barber has been the CEO of the company since 2011. | Commercial Services |
- Stock Market
- Insiders
- Edward Lindup